HopeStage
Back to all studies
CompletedNCT02930005

Two Add-On Medicines for Psychosis: A Feasibility Study

About this titleRead the official source — NCT02930005
Medication studyAges 18–60United StatesSchizophrenia
The study in practice

Understand this study

Who was this study for?

Listed age limits: 18 years to 60 years.

Listed locations
HoustonSee all locations and recruitment
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.

Get this study by email

HopeStage may email me about this study.
Loading the security check...
Study clarity

Study information

Study start dateAugust 7, 2015
Recruitment status
Completed
Enrollment listed in the registry
8
Sponsor
The University of Texas Health Science Center, Houston
Sponsor type
University
Study type
Drug
Intervention type
Drug
Study phase
Phase 2Usually explores whether the intervention may work, while continuing to monitor safety.
Locations
United States
Age range
From 18 Years to 60 Years
Official registry ID
NCT02930005
Official title
Show the full official title

A Pilot Open-label Trial of Pentosan Polysulfate Sodium and Meclofenamic Acid As Adjunctive Treatments in Patients With Psychotic Disorders

Looking for a study you can join?

Explore recruiting studies

Recruitment & locations

Completed

Houston

Interested in joining this study?

HopeStage may email me about this study.
Loading the security check...
FAQ

Questions about this study

Who is behind this study?

The study sponsor is The University of Texas Health Science Center, Houston, a university.

Did this study involve medication?

Yes. The study involved medication, including Meclofenamic acid and Pentosan polysulfate sodium.

Who was this study for?

Listed age limits: 18 years to 60 years.

Want to explore more studies?

Explore studies